Patents by Inventor Juncheng Zheng

Juncheng Zheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11988317
    Abstract: An adaptive sealing device for pipeline porous leakage. The device includes a pressure protection device and an encircling sealing rubber cover. The pressure protection device is used to pressurize and seal the pipeline by the encircling sealing rubber cover. The device further includes a control mechanism connected with the pressure protection device for adjusting the sealing pressure of the pressure protection device on the pipeline. The device further includes an anti-retraction mechanism connected with the pressure protection device and the control mechanism for limiting the pressure protection device and/or the control mechanism.
    Type: Grant
    Filed: February 23, 2023
    Date of Patent: May 21, 2024
    Assignee: CHANGZHOU UNIVERSITY
    Inventors: Hong Ji, Jie Guo, Ke Yang, Juncheng Jiang, Zhixiang Xing, Kai Zheng
  • Publication number: 20240160057
    Abstract: Embodiments of the present application provide a spliced display panel and a spliced display device. In the spliced display panel provided by the embodiments of the present application, a second display module is disposed on a non-display surface of a first display module and corresponding to a spliced region.
    Type: Application
    Filed: April 13, 2022
    Publication date: May 16, 2024
    Applicant: TCL China Star Optoelectronics Technology Co., Ltd.
    Inventors: Jun ZHAO, Bin ZHAO, Juncheng XIAO, Hongyuan XU, Feng ZHENG, Wenxue HUO
  • Publication number: 20210078941
    Abstract: The invention belongs to the pharmaceutical manufacturing field, which relates to a novel process for the preparation of substituted phenylacetic acids derivatives, especially relates to the preparation of 2-(4-(2-oxocyclopentyl)phenyl)propanoic acid. The process for the preparation of the precursor form of loxoprofen which use 1,4-di-halobenzyl compounds or disubstituted benzyl compounds as starting material, is through the substitution reaction of cyclopentanone groups or its precursor compounds. Wherein X is halogen, L1 is a suitable leaving group selected from halogen, OH, OMs, OTs, OTf and the like; L2 is a suitable leaving group selected from halogen, CN, OH, —CH2OH, —CHO, CH3NO2, ester group, —NR4R5, OTf, OTs, OMs, —C?CR6, —C?CR7 and the like, wherein R4, R5, R6, R7 are short chain alkyl groups; Z is cyclopentanone group and its precursor form selected from and the like; R3 is short chain alkyl groups.
    Type: Application
    Filed: August 7, 2018
    Publication date: March 18, 2021
    Applicant: Jiangsu Ruike Medical Science And Technology Co., Ltd.
    Inventors: Jieping Li, Zhaobo Gao, Bing Chai, Hui Zheng, Shengmin Liu, Aqing Liu, Bibao Guo, Juncheng Zheng, Changfa Wang, Weiwei Lu
  • Patent number: 9242965
    Abstract: The present invention is directed to an efficient process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form of formula I wherein R1 and R2 independently denote C1-3-alkyl groups and X? denotes an acid anion, such as the chloride, bromide, tosylate, mesylate or trifluoroacetate anion, with high quality, and a process for synthesis of EGFR tyrosine kinase inhibitors with heterocyclic quinazoline, quinoline or pyrimidopyrimidine core structure, using the acid addition salt I and activated derivatives thereof as intermediates.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: January 26, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Juncheng Zheng, Da Deng, Guanghua Lv, Jun Yan, Joerg Brandenburg, Jutta Kroeber, Ulrich Scholz
  • Publication number: 20150183764
    Abstract: The present invention is directed to an efficient process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form of formula I wherein R1 and R2 independently denote C1-3-alkyl groups and X? denotes an acid anion, such as the chloride, bromide, tosylate, mesylate or trifluoroacetate anion, with high quality, and a process for synthesis of EGFR tyrosine kinase inhibitors with heterocyclic quinazoline, quinoline or pyrimidopyrimidine core structure, using the acid addition salt I and activated derivatives thereof as intermediates.
    Type: Application
    Filed: December 19, 2014
    Publication date: July 2, 2015
    Inventors: Juncheng ZHENG, Da Deng, Guanghua LV, Jun Yan, Joerg Brandenburg, Jutta Kroeber, Ulrich Scholz
  • Patent number: 8895780
    Abstract: Disclosed is a method for the synthesis of N—H or N-alkyl 2-propynamides useful as intermediate in the manufacture of pharmaceutically active ingredients.
    Type: Grant
    Filed: August 29, 2013
    Date of Patent: November 25, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Da Deng, Juncheng Zheng
  • Publication number: 20140066655
    Abstract: Disclosed is a method for the synthesis of N—H or N-alkyl 2-propynamides useful as intermediate in the manufacture of pharmaceutically active ingredients.
    Type: Application
    Filed: August 29, 2013
    Publication date: March 6, 2014
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Da DENG, Juncheng Zheng